RaQualia Pharma Inc. is an R&D focused drug discovery company. It primarily uses exploratory research into small molecule compounds to discover the “seeds” of new drugs, and out-licenses development and marketing rights to pharmaceutical companies and others. The company is involved from exploratory research through the early clinical development stage (Phase II clinical trials). It develops new drugs targeting a wide range of fields including pain, gastrointestinal disorders, cancer, and immunological disorders.